Alaunos Therapeutics logo

Alaunos Therapeutics

TCRT | NASDAQ
Chart Builder DCF Calculator
$1.62
-$0.01 (-0.61%)
At close: Nov 16, 2026, 3:59 PM ET
$1.56
-$0.06 (-3.70%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.61%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
18.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1000/1021 (Top 98%)

Key Statistics

Market Data

Market Cap $5.57M
1D Range
1.58 1.68
52W Range
0.74 4.36

Valuation (TTM)

PE -0.83
PB 8.55
EV/EBITDA -1.37

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Librar...

Sector Healthcare
Industry Biotechnology
Employees 1
IPO Date Aug 24, 2005
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.